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BACKGROUND: Genome-wide association studies have identiﬁed several common risk loci for schizophrenia
(SCZ). In parallel, neuroimaging studies have shown consistent ﬁndings of widespread white matter disconnectivity
in patients with SCZ.
METHODS: We examined the role of genes in brain connectivity in patients with SCZ by combining transcriptional
proﬁles of 43 SCZ risk genes identiﬁed by the recent genome-wide association study of the Schizophrenia Working
Group of the Psychiatric Genomics Consortium with data on macroscale connectivity reductions in patients with
SCZ. Expression proﬁles of 43 Psychiatric Genomics Consortium SCZ risk genes were extracted from the
Allen Human Brain Atlas, and their average proﬁle across the cortex was correlated to the pattern of cortical
disconnectivity as derived from diffusion-weighted magnetic resonance imaging data of patients with SCZ (n 5 48)
and matched healthy controls (n 5 43).
RESULTS: The expression proﬁle of SCZ risk genes across cortical regions was signiﬁcantly correlated with the
regional macroscale disconnectivity (r 5 .588; p 5 .017). In addition, effects were found to be potentially speciﬁc to
SCZ, with transcriptional proﬁles not related to cortical disconnectivity in patients with bipolar I disorder (diffusion-
weighted magnetic resonance imaging data; 216 patients, 144 controls). Further examination of correlations across
all 20,737 genes present in the Allen Human Brain Atlas showed the set of top 100 strongest correlating genes to
display signiﬁcant enrichment for the disorder, potentially identifying new genes involved in the pathophysiology
of SCZ.
CONCLUSIONS: Our results suggest that under disease conditions, cortical areas with pronounced expression of
risk genes implicated in SCZ form central areas for white matter disconnectivity.
Keywords: Brain network, Connectivity, Connectomics, Diffusion MRI, Gene expression, Psychiatry, SchizophreniaISShttp://dx.doi.org/10.1016/j.biopsych.2016.07.012Schizophrenia (SCZ) is a psychiatric disorder that is character-
ized by hallucinations, delusions, a loss of initiative, and
cognitive dysfunction. The illness has an estimated heritability
up to 85% (1,2), with the recent genome-wide association study
(GWAS) of the Schizophrenia Working Group of the Psychiatric
Genomics Consortium (PGC) identifying at least 108 common
associated loci (3). The disorder is also reported to include
reductions in synapses (4,5), dysfunction of neurotransmitters
(6), loss of gray matter volume (7), and alterations in brain
connectivity architecture (8–13)—effects that together have been
posited to lead to changes in neural communication efﬁcacy and
affected information integration (14,15). Notably, twin (16,17) and
family studies (18,19) have shown the high heritability of global
white matter disconnectivity, suggesting that risk genes play a
role in mediating changes in white matter volume (20–22) and
more speciﬁcally corticocortical pathways (23–25). The patho-
genetic mechanisms of how these risk genes relate to alter-
ations in connectome structure remain unknown.
Animal models represent a valuable tool for studying the
underlying genetic mechanisms for brain phenotypes (26,27).& 2016 Society o
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SEE COMMENTAFor example, mouse models have shown that the expression
of risk genes affects neural function and cognitive processing
(26) and dysfunction of subcortical structures (27). An addi-
tional approach involves the examination of brain phenotypes
in the context of transcriptional proﬁles (28–30). With genes
known to have distinct expression across brain regions, an
advantage of this method is the possibility to investigate
region-speciﬁc expression patterns of disease-associated
genes, which in turn can lead to insights in pathogenetic
mechanisms of morphologic brain changes in disease con-
ditions (31). Adopting this approach, we performed a cross-
correlation study in which we combined comprehensive
expression levels of SCZ risk genes extracted from the
open database of the Allen Human Brain Atlas (AHBA) (32)
with data from diffusion-weighted magnetic resonance
imaging (MRI) in patients with SCZ. SCZ risk genes were
selected as the set of single genes on risk loci identiﬁed by
the Schizophrenia Working Group of the PGC, and their
pattern of expression across cortical areas was cross-
correlated with data on macroscale disconnectivity derivedf Biological Psychiatry. This is an open access article under the
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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correlation analysis showed default transcriptional proﬁles
of SCZ risk genes across the cortex to be associated with
cortical patterns of macroscale disconnectivity, indicating
regions with pronounced expression of risk genes to bear
the strongest reductions in corticocortical connectivity
observed with SCZ.
METHODS AND MATERIALS
Cortical Gene Expression of SCZ Risk Genes
The AHBA (32) was used to extract transcriptional proﬁles
across brain areas, including a unique database of expression
levels of 20,737 genes represented by 58,692 probes across the
complete cortical mantle as collected from postmortem brains
of six human donors without a history of psychiatric or neuro-
pathological disorders (summary of demographics shown in
Supplemental Table S1). With data of all six donors available for
the left hemisphere (two for the right hemisphere), samples of
the left hemisphere were included for analysis. Cortical samples
were volumetrically mapped to the Desikan–Killiany cortical
parcellation atlas (DK; 57 regions per hemisphere) (Figure 1)
(33), computing the minimal Euclidean distance of the reported
Montreal Neurological Institute three-dimensional coordinates of
each donor sample to the Montreal Neurological Institute
coordinates of all voxels of FreeSurfer’s software’s fsaverage
subject (available at http://surfer.nmr.mgh.harvard.edu/)
(Supplemental Methods). A maximal distance threshold of 1
mm was applied (Supplemental Methods). Next, a gene expres-
sion proﬁle was computed for each DK region by averaging the
expression proﬁles of the donor samples mapped to that
particular DK region. The recent GWAS study of the PGC
reported that 43 of 108 SCZ risk loci were linked to a single2 Biological Psychiatry ]]], 2016; ]:]]]–]]] www.sobp.org/journalgene (3). Default expression levels of those 43 single PGC genes
(tabulated in Supplemental Table S2) were extracted from the
total set of 20,737 genes (Supplemental Methods) and com-
bined into a schizophrenia risk gene expression (SRGE) score by
averaging the AHBA normalized expression levels across the
selected 43 PGC genes, per cortical area (Figure 2A). Two post
hoc analyses were performed in which additional SRGE proﬁles
were examined by 1) including an additional set of 15 genes
located within 500 kb of the 108 PGC loci, resulting in a total of
43 1 15 additional SCZ risk genes, and 2) including all genes
(N 5 349, including both single and multigene-associated loci)
related to the 108 SCZ-associated loci. Data of these post hoc
analyses are reported in the Supplemental Results.
A SRGE proﬁle was also computed for the set of 85 genes
as reported by the recent meta-analysis by Chen et al. (34) in
which the top ﬁndings of GWAS were combined and sum-
marized. While the Chen et al. dataset included only 13 single
genes (limiting cross-correlation analysis), multigene associa-
ted loci were included in this validation analysis (Supplemental
Table S2).
Diffusion-Weighted Imaging Macroscale
Connectivity in Patients
3T MRI scans were acquired for a group of 48 patients with
SCZ and 43 age- and sex-matched healthy control subjects
(demographics shown in Supplemental Table S3), a dataset
previously examined in the context of hub and rich club
disconnectivity in SCZ (9). In short, for each participant, two
diffusion-weighted imaging (DWI) sets of 30 diffusion-
weighted volumes (b 5 1000 s/mm2) and ﬁve unweighted
volumes were acquired. Compressed sensing techniques were
applied to determine the diffusion proﬁle for each voxel,
allowing for the reconstruction of complex ﬁber architectures,Figure 1. Overview of data proces-
sing and analysis. (I-A) Streamline
tractography was used to reconstruct
individual white matter corticocortical
pathways. (I-B) Corticocortical con-
nectivity was reconstructed between
all 57 Desikan–Killiany (DK) regions
and (I-C) the patient-control pattern
of regional disconnectivity was com-
puted. (II-A) Cortical gene expression
of 20,737 genes was extracted from
the Allen Human Brain Atlas (AHBA).
(II-B) The reported AHBA samples
were mapped to cortical areas of the
DK atlas. (II-C) Gene expression
levels of the 43 Psychiatric Genomics
Consortium schizophrenia risk genes
(3) were extracted, and for each DK-
57 region a schizophrenia risk gene
expression value was computed as
the average of the AHBA-normalized
(32) expression values of the 43
schizophrenia risk genes. (III) The
obtained cortical schizophrenia risk
gene expression proﬁle was corre-
lated to disease-related macroscale
connectivity reductions derived from
neuroimaging data.
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matter pathways (9) (Supplemental Methods). High-resolution
anatomical T1-weighted images were used for tissue classi-
ﬁcation, surface reconstruction, and subsequent division of the
cortical mantle into 57 distinct areas according to the DK atlas
(i.e., the atlas also used to map the AHBA data). A structural
connectome map was formed for each individual dataset by
determining, for each pair of cortical regions, whether they were
connected by corticocortical streamlines from the total set of
reconstructed ﬁber streamlines. Connection strength of the
resulting corticocortical pathways was taken in terms of number
of interconnecting streamlines (NOS) (14,35). We also included
the examination of streamline density (SD), computed as the
NOS between two regions dividing off the volume of the two
connected regions (35,36), to correct for potential differences in
regional and total brain volume as often reported in patients
with SCZ. Fractional anisotropy (FA) and mean diffusivity (MD)
of tracts were examined to obtain insight into potential changes
in microstructural organization. Next, for each of the individual
datasets, for each of the 57 DK cortical areas, we assessed
the metric of regional connectivity [i.e., nodal strength in terms
of graph theoretical connectome studies (37); see Supplemental
Methods], computed as the total sum (i.e., nonzero mean in
case of FA/MD) of connectivity per region. Subsequently,
patient-control between-group differences in regional discon-
nectivity were computed as the ratio of change in cortical
connectivity between the patient and control populations (i.e.,
[patients – controls]/[controls]) per cortical area (Figure 2B). The
resulting cortical map reﬂected regional variation in macroscale
disconnectivity in the group of patients compared to the group
of controls. Expressing patient-control differences per cortical
area in terms of t statistics reveals consistent ﬁndings
(Supplemental Results). In addition, similar ﬁndings are also
observed when using coarser (i.e., DK-34 instead of 57 regions
per hemisphere) or ﬁner (i.e., DK-111 regions per hemisphere)
parcellation versions of the DK atlas and the Automatic
Anatomical Labeling atlas (data shown in Supplemental
Information).
Cross-Modal Gene Connectivity Analysis
Associations between transcriptional proﬁles of risk genes and
patient-control differences in macroscale connectivity wereFigure 2. Side-to-side view of (A) cortical pattern of gene expression of
schizophrenia risk genes and (B) cortical distribution of reductions in
macroscale regional disconnectivity between patients and controls across
the mapped Desikan–Killiany regions.assessed using Pearson’s correlation analysis. Statistical evalua-
tion was performed using permutation testing (e.g., selecting
equally sized sets of random genes and examining their null
effect correlation to cortical macroscale disconnectivity [10,000
permutations examined; see Supplemental Information]). In addi-
tion, because averaging gene expression across genes in distinct
molecular pathways (as we did for the SRGE proﬁle) can be
nonoptimal given that signals of different sources are mixed, we
alternatively computed individual correlations between all of the
43 single PGC genes and the pattern of cortical disconnectivity
and then averaged their absolute correlation values. Similarly,
permutation testing selecting equally sized sets of random genes
and examining their average absolute null effect correlation was
used for statistical evaluation. The false discovery rate (FDR) was
used to correct for multiple testing (Supplemental Information).
Gene Classes
Correlation analyses were performed for the six speciﬁc gene
classes as speciﬁed by the Schizophrenia Working Group of
the PGC (3). This PGC subdividion included the grouping of 35
genes (of the 349 PGC risk genes related to the 108 loci) into
six subclasses, following current hypotheses on disease
etiology and treatment. These groupings were related to the
following: 1) therapeutic targets (2 genes); 2) glutamatergic
neurotransmission (6 genes); 3) calcium signaling (7 genes); 4)
synaptic function and plasticity (9 genes); 5) other neuronal ion
channels (5 genes); and 6) neurodevelopment (7 genes).
Average gene expression proﬁles were computed for each
class and correlated to the cortical pattern of DWI macroscale
disconnectivity.
Strongest Correlating Genes
Next, we cross-correlated the regional expression proﬁle of
each of the 20,737 AHBA genes individually with the pattern of
MRI disconnectivity. The top 100 (and additionally top 200)
strongest correlating genes (absolute correlations; all genes
listed in Supplemental Table S3) were further examined by
means of three post hoc analyses.
We ﬁrst examined the role of the selected top 100 (and
additionally top 200) strongest correlating genes using a
PubMed and Google Scholar search, in which we searched
for scientiﬁc publications that reported on the involvement of
these genes in SCZ or other psychiatric disorders. For each of
the strongest correlating genes, we searched for the combina-
tion of (gene symbol) AND [(schizophrenia) OR (other psychi-
atric disorder)] and listed the publications reporting abnorma-
lities in disease. The category of “other psychiatric disorder”
included bipolar disorder, autism, attention-deﬁcit/hyperactivity
disorder, major depressive disorder, obsessive-compulsive dis-
order, or alcohol addiction. We assessed statistical evaluation
on the number of reports observed by means of computing the
level of chance of randomly selecting 100 genes involved in
SCZ out of the total number of 20,737 AHBA genes, with an
estimated total number of 2800 genes involved in the disorder
[based on (38); see Supplement for details].
Second, we examined the selected set of top 100 (and
additionally top 200) correlating genes by cross-validating these
genes with the recently published GWAS data of the PGC (3)
(Supplement) extracting odds ratios and p values of the set ofBiological Psychiatry ]]], 2016; ]:]]]–]]] www.sobp.org/journal 3
Figure 3. Positive association between default schizophrenia risk gene
expression (SRGE, x-axis) and between-group differences in macroscale
regional disconnectivity (number of streamlines, y-axis). A similar positive
correlation was observed for streamline density effects (Supplemental
Figure S1).
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the subset of genes out of these top strongest correlating genes
that did not reveal any hits in our PubMed/Google Scholar search
(i.e., examining the set of genes that have not previously been
mentioned in the context of SCZ or other psychiatric disorders).
Third, we performed gene pathway analysis for the top
scoring genes using Protein ANalysis THrough Evolutionary
Relationships (PANTHER) analysis (39) and the web interface
of ConsensusPathDB tool (40). Reported p values were
corrected for multiple comparisons using FDR.
RESULTS
Correlation analysis revealed a signiﬁcant correlation between
SRGE proﬁle and the pattern of white matter disconnectivity
(NOS: r 5 .588; p 5 .017 [Figure 3]; SD: r 5 .548, p 5 .0277
[Supplemental Figure S1]; permutation testing, both surviving
FDR), indicating that cortical regions with the highest expres-
sion of risk genes overlap with areas that show the largest
reduction in white matter connectome connectivity. This corre-
lation was particularly observed for metrics reﬂecting reductions
in regional connectivity in terms of white matter volume [i.e.,
NOS and SD (35)], with no correlation effects observed when
examining MRI metrics of white matter microstructure (i.e., FA
[p 5 .982] and MD [p 5 .831]). Alternatively, taking the average
value across all individual correlations of the 43 PGC genes
conﬁrmed a positive relationship between the pattern of
expression of risk genes and regional disconnectivity (average
r 5 .322, p 5 .0005, permutation testing [Supplemental Figure
S2]). Analysis of the set of 43 1 15 genes within 500 kb and the
subset of 349 genes within all 108 PGC-identiﬁed loci revealed
similar ﬁndings (Supplemental Results).
No correlation was observed between SRGE and disease-
related pattern of cortical thinning (computed as the ratio of
change in cortical thickness between patients and controls,
r 5 .2803, p 5 .1422, permutation testing [Supplement]),
suggesting an effect speciﬁc to patterns of regional connec-
tome disconnectivity.
Similar associations were also observed with gene expres-
sion levels based on 85 SCZ risk genes reported in the Chen
et al. study (34) (NOS: r 5 .600, p 5 .0071; SD: r 5 .585,
p 5 .0058; permutation testing [Supplemental Figure S3]).
PGC Gene Classes
We examined the subset of 35 risk genes speciﬁcally highlighted
and grouped by the PGC into six functional gene classes following
current hypotheses on SCZ etiology and treatment (3). Correlation
analysis between pattern of disconnectivity and pattern of gene
expression showed the strongest association for the class of
genes involved in neuronal calcium signaling (Table 1), suggesting
a potentially strong inﬂuence of this class of genes on reductions
in macroscale connectivity in patients (NOS: r 5 .680,
p 5 .0008 [Figure 4]; SD: r 5 .632, p 5 .0018; all surviving FDR
[Supplemental Figure S4]). Given this strong correlation, we further
examined to what extent our main effect (i.e., SRGE based on 43
single PGC genes) was driven by the subclass of neuronal calcium
signaling genes. Excluding the subclass of neuronal calcium
signaling genes from the set of single genes (i.e., 43 minus the
5 of 7 calcium signaling genes) (Supplemental Methods) still
revealed a signiﬁcant correlation between the expression proﬁle4 Biological Psychiatry ]]], 2016; ]:]]]–]]] www.sobp.org/journalof the remaining set of 38 genes and regional disconnectivity
(r 5 .576, p 5 .024; permutation testing).
Top Strongest Correlating Genes
We continued by examining the correlation for each of the
20,737 AHBA genes individually and selecting the top 100
(and additionally top 200) strongest correlating genes. First, a
PubMed/Google Scholar search on the set of top 100 (all p ,
1.56 3 10–6, all individually surviving strict Bonferroni correc-
tion) genes revealed 34 genes to be previously reported in
context of SCZ in at least one scientiﬁc study, which is 2.2
times more than one would expect under the null condition
(p 5 1.35 3 10–5 [Supplemental Table S3 lists all of the found
studies]). In addition, of the remaining 66 genes, another 17
genes were previously reported in the context of other
psychiatric disorders, including bipolar disorder (5 genes),
autism spectrum disorder (4 genes), obsessive-compulsive
disorder (3 genes), attention-deﬁcit/hyperactivity disorder
(3 genes), and alcohol addiction (1 gene) (Supplemental
Table S4). Examining the top 200 strongest correlating genes
(again, all individually surviving Bonferroni correction) revealed
similar ﬁndings: 96 genes were found to be previously
reported in the context of psychiatric conditions, with 71
genes reported in SCZ (p , .0001) and 25 genes reported in
context of other psychiatric conditions (Supplemental Results).
Second, we cross-referenced the subset of top 100 stron-
gest correlating genes with the recently published GWAS data
of the PGC (3), which revealed a trend toward higher involve-
ment of this subset of genes in the disorder with an average
odds ratio deviating from 1 of 0.0372 (p 5 .0172; permutation
testing). In addition, speciﬁcally examining the subset of 49
genes not earlier reported in context of psychiatric disorders
also revealed a trend toward higher involvement (average PGC
odds ratios deviating from 1 of 0.0327, p 5 .110; permutation
testing), indicating the potential involvement of “new genes” in
the pathophysiology of SCZ. Similar effects were observed
Table 1. Correlation Analyses Gene Classes
Functional Class
No. of
Genes
Correlation
Coefﬁcient p Valuea
Neuronal Calcium Signaling 7 0.680 .0008
Glutamatergic
Neurotransmission
6 –0.112 .7520
Neurodevelopment 7 0.337 .3080
Synaptic Function and Plasticity 9 0.225 .5244
Other Neuronal Ion Channels 5 0.314 .3531
Therapeutic Targets 2 –0.383 .2152
ap values assessed with permutation testing (10,000 permutations).
Figure 4. Positive association between default gene expression levels of
the class of Psychiatric Genomics Consortium risk genes related to
neuronal calcium signaling (x-axis) and the pattern of macroscale discon-
nectivity (number of streamlines, y-axis). A similar positive correlation was
observed for streamline density effects (Supplemental Figure S3). SRGE,
schizophrenia risk gene expression.
Gene Expression and Disconnectivity in Schizophrenia
Biological
Psychiatrywhen we examined GWAS p values and odds ratios of the top
200 strongest correlating genes (Supplemental Results). This
was again true for the remaining subset of the not previously
reported 104 genes out of the top 200 strongest correlating
genes (average PGC odds ratio deviating from 1 of 0.0346, p 5
.048; permutation testing) (Supplement), suggesting potential
enrichment of the set of top strongest correlating genes in SCZ.
Third, PANTHER overrepresentation analysis (39) revealed
strong overrepresentation of the top 100 strongest correlating
genes in the biological processes of synaptic transmission
(p 5 1.80 3 10–8), cell–cell signaling (p 5 2.80 3 10–7), and
regulation of cell and protein localization (p 5 8.06 3 10–6;
all surviving FDR). Additional analysis by means of the web
interface of the ConsensusPathDB tool (40) showed signiﬁcant
overrepresentation of 54 gene ontology terms (tabulated in
Supplemental Table S4), centralized around processes involved
in cell–cell signaling and secretion (p ,1.15 3 10–3), protein
complex formation (p , 5.0 3 10–3), and regulation of synapse
structure or activity (p , 2.60 3 10–3; all FDR)—processes that
have all been reported to be involved in the pathophysiology of
SCZ (41–43). Examining the top 200 genes conﬁrmed these
ﬁndings, with PANTHER analysis highlighting overrepresenta-
tion of biological processes involved in synaptic transmission (p
, 1.31 3 10–5) and regulation of (ion) transmembrane transport
(p , 6.69 3 10–3; all surviving FDR). ConsensusPathDB
analysis revealed gene pathways related to formation and
regulation of synapses and cell–cell signaling (p , 1.00 3
10–3) and structure and activity of transporters and receptors
(p , 7.58 3 10–3; all FDR) (Supplemental Table S5).
A total set of 540 genes all individually survived strict
Bonferroni correction (i.e., showing a p , .05 corrected for
20,737 tests). A PGC GWAS cross-validation and overrepre-
sentation analysis for this set of 540 top-scoring genes
revealed similar pathways, including (regulation of) potassium
ion transmembrane transport, single organism signaling, and
cell communication (see Supplement for an overview).
Bipolar Disorder Validation
Analysis of the expression proﬁle of SCZ risk genes (SRGE)
and MRI connectivity reductions in the patients with bipolar
disorder did not reveal associations in terms of DWI NOS (p 5
.506), SD (p 5 .400), FA (p 5 .302), or MD (p 5 .078)
(Supplemental Results). Similarly, in further support of a
certain level of speciﬁcity of the reported effects to SCZ,
correlation analysis between bipolar risk gene expression
levels and the pattern of SCZ disconnectivity also did not
reveal signiﬁcant relationships in NOS, SD, nor FA/MD(Supplemental Results). In contrast, linking bipolar risk
gene expression levels to the MRI measurements of connec-
tivity in the bipolar group revealed a signiﬁcant inverse
association between bipolar risk gene expression levels and
regional disconnectivity in patients with bipolar disorder,
in particular as measured by means of changes in FA of
corticocortical tracts (set I: FA: r 5 –.530, p 5 .0007; set II: FA:
r 5 –.392, p 5 .0025; surviving FDR) (see Supplemental
Figure S5 and Supplemental Results for other connectivity
metrics).DISCUSSION
Our ﬁndings report the cortical transcriptional proﬁle of SCZ
risk genes to be associated with the phenotype of regional
white matter connectome disconnectivity in patients with SCZ.
This suggests that under disease conditions, cortical areas
with pronounced expression of risk genes might be central
areas for global white matter disconnectivity.
Our observations support and extend ﬁndings of studies
using genetic material from blood samples linking genetic
information to changes in brain morphology. The Enhancing
NeuroImaging Genetics through Meta-Analysis consortium, for
example, showed strong heritability of subcortical volume loss
in SCZ (44), and the deletion burden of SCZ-associated copy
number variations has been shown to be associated with
changes in anatomical and functional connectivity in patients
with SCZ (45).
Examining PGC gene subclasses showed a particularly
strong (but not exclusive) association between the pattern of
regional disconnectivity and the average expression proﬁle of
genes related to neuronal calcium signaling. Calcium signaling
has indeed been noted to be of particular importance in the
etiology of SCZ (46–48), with proteins such as RGS4, GAP43,
and parvalbumin regularly reported to have a role in the disorder
(47). In addition, a risk variant of calcium gene CACNA1C—a
gene repeatedly associated with SCZ—is involved in theBiological Psychiatry ]]], 2016; ]:]]]–]]] www.sobp.org/journal 5
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to white matter integrity loss in SCZ (49). Moreover, at the
cellular level, calcium signaling has been noted to play a central
role in the formation, degeneration, and modiﬁcation of neuro-
nal connectivity (50,51) with up- and down-regulation of
calcium signaling leading to reductions in dendritic volume
and branching (50,52). SCZ indeed involves pronounced reduc-
tions in spine density of layer 3 pyramidal cells in frontal and
temporal association regions (5), with these changes argued to
be related to the extent of macroscale white matter disconnec-
tivity (53).
Pathway analysis of the top 100 (and additionally top 200)
strongest correlating genes revealed a particular role for
pathways involved in the formation of synapses and protein
complexes (41,42,54). A literature search on these top-
correlating genes suggested a substantial part (51/100) to be
previously reported in the context of psychiatric disorders,
which makes us believe that additional examination of the
remaining set of genes may a fruitful approach to identify new
risk genes (55). This is strengthened by two of our observa-
tions: ﬁrst, cross-referencing the set of remaining genes not
earlier reported in context of pyschiatric disorder with GWAS
data of the PGC (3) reveals potential enrichment of this subset
of genes in the disorder, showing higher odds ratios deviating
from 1 and overall low GWAS p values. Second, several of the
top-scoring genes have been earlier reported in context of the
disorder. We stress, for example, the recently discovered gene
C4A within the major histocompatibility complex on chromo-
some 6 (56), which scored particularly high out of all possible
correlations, namely position 15 out of all 20,737 genes (r 5
–.6978, p 5 1.6215 3 10-9; surviving FDR and strict Bonfer-
roni) (Supplement).
Moreover, of all 11,307 genes showing an inverse relation-
ship with the cortical pattern of macroscale disconnectivity,
C4A turned out to be the second strongest correlating gene,
with only ZFP36L1 showing a stronger inverse association (r 5
–.7102, p 5 6.1183 3 10–10)—again, a gene that was earlier
noted to be involved in the disorder (57). As suggested for C4A
(56), ZFP36L1 (58) is a gene related to regularization proc-
esses. Underlying pathogenetic mechanisms of both observed
positively versus inversely correlated effects remain elusive for
now. A potential explanation might include a distinction
between genes having a regulatory role (e.g., C4A and
ZFP36L1) compared with genes related to biological proc-
esses, such as the subset of genes involved in calcium
signaling.
Our ﬁndings also show potential speciﬁcity of the observed
effects to SCZ. Cortical expression proﬁles of SCZ risk genes
did not show correlations to the pattern of regional white
matter disconnectivity in patients with bipolar I disorder, nor
did we observe effects of bipolar risk genes on macroscale
disconnectivity in the group of patients with SCZ. In contrast,
in favor of potential disorder-speciﬁc associations, the expres-
sion proﬁle of bipolar risk genes did show a signiﬁcant
correlation with the cortical pattern of FA-related disconnec-
tivity in patients with bipolar disorder (59). These ﬁndings
argue for potentially converging pathophysiologic mecha-
nisms in the two disorders (60). Indeed, the diffusion-
weighted MRI metric of FA is often interpreted as a proxy of
white matter microstructure—rather than a metric of tract6 Biological Psychiatry ]]], 2016; ]:]]]–]]] www.sobp.org/journalvolume (35)—and studies have suggested white matter abnor-
malities in bipolar disorder to be concentrated around a
reduction in myelin content rather than abnormalities in axonal
geometry or tract volume (61,62). This is in contrast to SCZ,
where both myelination deﬁcits and axon abnormalities have
been reported (63).
Several remarks have to be made when interpreting the
ﬁndings of our cross-correlation study. The transcriptional
proﬁles obtained from the AHBA include data from non-
psychiatric postmortem donors, which was cross-correlated
to cortical patterns of disconnectivity as derived from MRI
scans of a group of patients with SCZ and healthy controls.
This study design is therefore limited to examining relation-
ships between cortical patterns of gene expression and
regional macroscale disconnectivity across groups, with an
examination of possible individual patient effects thus out of
scope. However, the start of large-scale psychiatric brain
banks (e.g., the National Institute of Mental Health Brain
Collection (64) and the Netherlands Brain Bank Psychiatry,
http://www.nbb-psy.nl) may make the examination of a direct
link between postmortem-measured connectivity changes and
affected gene expression levels in individual patients possible
in the near future. We also note that DWI is a technique that
relies on water diffusion as an indirect marker for axon
geometry, which is currently the only technique suitable to
assess anatomical connectivity changes in patient populations
in vivo. Diffusion MRI is generally recognized to have limita-
tions with respect to the reconstruction of complex ﬁber
architectures and connectome mappings (35,65,66), effects
that may have potentially led to an underestimation of the
observed patient MRI effects.
Our ﬁndings suggest expression proﬁles of SCZ risk genes
across brain areas to coincide with patterns of white matter
disconnectivity in patients with SCZ, elucidating possible
genetic underpinnings of white matter connectivity disruptions
in the disorder. Linking expression levels to disease pheno-
types can form a valuable tool to provide insight into the
pathogenetic mechanisms of SCZ. Importantly, the applied
cross-modal analysis may include a potential powerful
approach for identifying new risk genes and gene pathways
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